Centre for Genomics Research at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Centre for Genomics Research at ASHG 2026 in Montréal: 1 presentation (1 poster).

Organization	ASHG 2026 Attendance
Centre for Genomics Research Gaithersburg, Maryland	1 Scientist
astrazeneca.com Public company~96,100 people CGR provides open-access genomics tools and data resources to researchers, and genomic insights to AstraZeneca drug-discovery teams. Published Nature research improving how large DNA deletions and duplications are characterized, part of its open genomics work. › Published Nature research improving how large DNA deletions and duplications are characterized, part of its open genomics work. 2026-02 · source Identified 22 genes tied to control of EBV infection and long-term chronic disease risk after common viral infection. 2026-01 · source Expanded its genomic datasets' diversity through strategic partnerships spanning 19 countries, supporting AstraZeneca's drug-discovery target research. 2025-12 · source Source: company newsroom Parent AstraZeneca Q2 revenue $15.4B, up 6% › Figures cover parent AstraZeneca overall, not CGR alone; full-year guidance was reaffirmed. · 2026-07-27 “Total Revenue \| 30,672 \| 9 \| 6 \| 15,384 \| 6 \| 5. At CER, Total Revenue is expected to increase by a mid-to-high single-digit % and Core EPS by a low double-digit %.” Source: results release Currently hiring: 824 open roles › Source: careers page	Poster Fri Oct 23 2:30 pm Part of Statistical Genetics and Genetic Epidemiology Poster Friday Session Scalable time-to-event association analysis for biobank-scale rare variant studies Exhibit & Poster Hall · Board 8449F Collaborators: Duke University, The University of Melbourne Phenome-wide associationRare variantsGenome-wide association studyComputational tools

Organization

ASHG 2026 Attendance

Centre for Genomics Research

Gaithersburg, Maryland

1 Scientist

astrazeneca.com

Public company~96,100 people

CGR provides open-access genomics tools and data resources to researchers, and genomic insights to AstraZeneca drug-discovery teams.

Published Nature research improving how large DNA deletions and duplications are characterized, part of its open genomics work.

›

Published Nature research improving how large DNA deletions and duplications are characterized, part of its open genomics work.

2026-02 · source

Identified 22 genes tied to control of EBV infection and long-term chronic disease risk after common viral infection.

2026-01 · source

Expanded its genomic datasets' diversity through strategic partnerships spanning 19 countries, supporting AstraZeneca's drug-discovery target research.

2025-12 · source

Source: company newsroom

Parent AstraZeneca Q2 revenue $15.4B, up 6%

›

Figures cover parent AstraZeneca overall, not CGR alone; full-year guidance was reaffirmed. · 2026-07-27

“Total Revenue | 30,672 | 9 | 6 | 15,384 | 6 | 5. At CER, Total Revenue is expected to increase by a mid-to-high single-digit % and Core EPS by a low double-digit %.”

Source: results release

Currently hiring: 824 open roles

›

Source: careers page

Poster

Fri Oct 23
2:30 pm

Part of Statistical Genetics and Genetic Epidemiology Poster Friday Session

Scalable time-to-event association analysis for biobank-scale rare variant studies

Exhibit & Poster Hall · Board 8449F

Collaborators: Duke University, The University of Melbourne

Phenome-wide associationRare variantsGenome-wide association studyComputational tools